Stock Research: Surgery Partners

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Surgery Partners

NasdaqGS:SGRY US86881A1007
34
  • Value
    64
  • Growth
    53
  • Safety
    Safety
    21
  • Combined
    29
  • Sentiment
    39
  • 360° View
    360° View
    34
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Surgery Partners, Inc. is a healthcare services company operating a national network of surgical facilities and ancillary services. It primarily focuses on surgical facility services including ambulatory surgery centers (ASCs), surgical hospitals, anesthesia services, urgent care facilities, and multi-specialty physician practices across various specialties like orthopedics, pain management, ophthalmology, gastroenterology, and general surgery. The company operates in 31 states across the United States. In the last fiscal year, the company had 15000 employees, a market cap of $2846 million, profits of $835 million, and revenue of $3114 million.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 34 (better than 34% compared with alternatives), overall professional sentiment and financial characteristics for the stock Surgery Partners are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Surgery Partners. The consolidated Growth Rank has a good rank of 53, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 53% of competitors in the same industry. In addition, the consolidated Safety Rank has a safer rank of 64 which means that the company has a financing structure that is safer than 64% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the consolidated Value Rank has a less desirable rank of 21 which means that the share price of Surgery Partners is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is higher than for 79% of alternative stocks in the same industry. The consolidated Sentiment Rank also has a low rank of 39, which means that professional investors are more pessimistic about the stock than for 61% of alternative investment opportunities. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
21 31 12 8
Growth
53 46 93 93
Safety
Safety
64 60 49 15
Sentiment
39 19 63 17
360° View
360° View
34 20 62 13
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
73 49 76 77
Opinions Change
40 50 50 50
Pro Holdings
n/a 7 65 13
Market Pulse
22 24 24 12
Sentiment
39 19 63 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
21 31 12 8
Growth
53 46 93 93
Safety Safety
64 60 49 15
Combined
29 42 52 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
23 22 17 1
Price vs. Earnings (P/E)
31 49 33 40
Price vs. Book (P/B)
50 51 50 16
Dividend Yield
1 1 1 1
Value
21 31 12 8
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
80 78 68 56
Profit Growth
35 20 100 79
Capital Growth
51 59 82 49
Stock Returns
35 27 67 93
Growth
53 46 93 93
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
37 41 40 26
Refinancing
80 75 59 42
Liquidity
35 32 43 31
Safety Safety
64 60 49 15

Similar Stocks

Discover high‑ranked alternatives to Surgery Partners and broaden your portfolio horizons.

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.